US20050220734A1 - Therapy for melanin related afflictions - Google Patents

Therapy for melanin related afflictions Download PDF

Info

Publication number
US20050220734A1
US20050220734A1 US10/817,036 US81703604A US2005220734A1 US 20050220734 A1 US20050220734 A1 US 20050220734A1 US 81703604 A US81703604 A US 81703604A US 2005220734 A1 US2005220734 A1 US 2005220734A1
Authority
US
United States
Prior art keywords
botulinum toxin
skin
method
botulinum
melanin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/817,036
Inventor
Eric First
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Priority to US10/817,036 priority Critical patent/US20050220734A1/en
Assigned to ALLERGAN, INC. reassignment ALLERGAN, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FIRST, ERIC R.
Publication of US20050220734A1 publication Critical patent/US20050220734A1/en
Application status is Abandoned legal-status Critical

Links